Objective. Determine the effect of endogenous estrogen versus estrogen replacement therapy (ERT) on bladder blood flow (BBF) and estrogen receptors (ERs). Methods. BBF was determined with radiolabeled microspheres in luteal, follicular, pregnant, oophorectomized (Ovx) sheep, and Ovx sheep with ERT. Estrogen receptors (ERa, ERb) were quantified using Western blot analysis. Results. Compared to luteal and follicular ewes, BBF was reduced in pregnancy and following oophorectomy. Estrogen replacement therapy in Ovx sheep restored BBF to luteal levels. Estrogen receptor a predominated, whereas ERb was not detectable. Estrogen receptor-a levels were unaffected by the ovarian cycle and increased in pregnancy, as well as in Ovx sheep with and without chronic ERT. Conclusion. The combination of diminished BBF and elevated ERa levels in both pregnant and Ovx sheep suggests an inverse relationship between BBF and ERa in the bladder. Although chronic ERT in Ovx sheep restored BBF, it did not restore ERa back to luteal levels.
INTRODUCTION
Systemic estrogen has many effects on organ function and blood flow that vary depending on the individual vascular bed being studied. Female reproductive tissues like the ovary, vagina, and uterus are exquisitely sensitive to the vasodilatory effects of estrogen. [1] [2] [3] Uterine vascular bed responses are partially reduced by giving combination treatment with progesterone. [4] [5] [6] In numerous species including sheep, the systemic estrogen to progesterone ratio is elevated during the follicular phase when uterine blood flow is greatest, while during the luteal phase, the estrogen to progesterone ratio is depressed and uterine blood flow is at its nadir. 7 Pregnancy is characterized by high endogenous estrogen levels in a progesterone-dominated state with substantial rises in uterine blood flow. 4, 5, 8 The relationship between systemic estrogen replacement and bladder volumetric perfusion has been studied [9] [10] [11] [12] These studies show an increase in bladder perfusion with estrogen replacement therapy (ERT) and a fall in blood flow with oopherectomy. Bladder blood flow (BBF) has been estimated using a variety of different techniques, including Doppler ultrasound flow velocity, 12, 13 O 2 consumption, 14, 15 and microspheres (florescent and radioactive). 11, [16] [17] [18] There have also been studies confirming the presence of estrogen receptors (ERs) in the bladder and the effects of ERT on receptor levels during menopause. 19, 20 Numerous functional studies of the bladder have evaluated estrogen replacement and contractile function. They noted an increase in contractile function of bladder smooth muscle with estrogen treatment. [20] [21] [22] [23] [24] In vivo tissue oxygenation of the bladder is also increased with ERT 14, 15 as well as increases in angiogenesis, changes in bladder structure, 20, 22, 25 and detrusor muscle density in rabbits with ERT. 27 To our knowledge, the effect of endogenous estrogen on BBF and bladder ERs during the ovine ovarian cycle has not been studied. There have been several studies examining urethral blood flow during different phases of the menstrual cycle using Doppler ultrasound. No statistically significant differences were observed. [28] [29] [30] The changes in BBF during pregnancy are not known. We believe that alterations in endogenous steroids of ovarian origin may play a role in the maintenance and/or health of the bladder and the tissues of the pelvis. To our knowledge, this is the first study directly evaluating BBF in sheep in different endogenous and exogenous hormonal states using blood flow measurements.
OBJECTIVE
The primary objective of this study was to quantify the effects of endogenous and exogenous estrogen on bladder vascular resistance and BBF using a physiologically welldefined animal model for examining endocrine states of high and low estrogen. The secondary objective of this study was to determine the levels of ERa, and ERb in the bladder during these different hormonal states. We hypothesized that during physiological states of high endogenous estrogen (follicular phase and pregnancy) or exogenous ERT, BBF will increase and with oophorectomy as a surgical model of menopause, (i.e. with low estrogen), BBF will be reduced. Moreover, we hypothesize that ER levels will directly correlate with these changes in BBF.
METHODS
The current studies were approved by the Research Animal Care and Use Committee of the University of Wisconsin School of Medicine and Public Health.
Surgical Preparation 1,8,31
Prior to surgery, the animals were fasted and water removed for 12 to 24 hours. Anesthesia was induced with an intramuscular (IM) injection of ketamine (15 mg/kg; Midwest Vet Supply, Sun Prairie, WI) and atropine (12 mg/kg, Hospira Inc., Lake Forest, IL). Prophylactic IM antibiotics (400 000 U penicillin; Sandoz, Inc., Princeton, NJ; 4 mg/kg Gentamicin, Abraxis, Inc., Schaumburg, IL) were also given. A jugular vein catheter was inserted and advanced 20 to 30 cm to administer a continuous IV drip of 10% ketamine in 0.9% saline and 5% dextrose. Supplemental Nembutal (pentobarbital sodium 50 mg/ml; Sigma Chemical Co., St. Louis, MO) was given as needed throughout the procedure to insure an adequate plain of anesthesia was maintained. Surgeries were performed on 47 mixed western breed sheep (62 + 3.2 kg; 6 pregnant 120-130 days' gestation [term ¼ 147 days; n ¼ 6], 41 nonpregnant), which consisted of implantation of arterial and venous catheters inserted in both superficial saphenous vessels and advanced through the femoral circulation into the descending aorta and abdominal inferior vena cava, respectively. In addition, a left ventricle catheter was implanted via the left carotid artery. These catheters were exteriorized and maintained under heparin lock (100 IU/mL). Thirty of the nonpregnant animals had bilateral oophorectomy by midventral laparotomy. Postoperative 75 mg IM Flunixin Meglumine (Banamine, Schering-Plough, Palo Alto, CA) analgesia was administered immediately postsurgery and again at 24 hours. Animals were allowed access to food and water ad libitum throughout the remainder of the study. All animals were given IM penicillin (400 000 U) and Gentamicin (4 mg/kg) for 2 days and then every 3 days thereafter. The animals were returned to the laboratory on postoperative day 4 to 5 following surgery.
Bladder Blood Flow Measurements
Experiments to measure BBF were conducted at least 5 to 7 days postsurgery. In these studies, mean arterial pressure and heart rate were monitored continuously for 60 minutes, arterial pH, PO 2 , PCO 2 , hemoglobin, hematocrit, lactate, and glucose levels were measured intermittently, and all were in normal physiological ranges. 1, 7, 8, 31 . An injection of a randomly selected 15 um radioactive ( 153 Gd, 51 Cr, 113 Sn, 85 Sr, 95 Nb, and 46 Sc) microspheres (3-5 million spheres/injection) was given via the left ventricular catheter, while a blood reference sample was withdrawn (4.12 mL/min) from the descending aorta (via both saphenous artery catheters). 1 To establish time courses of changes in BBF relative to expected changes in estrogen and/or progesterone levels, hemodynamic monitoring and Microsphere injections were repeated.
Experimental Protocol for Intact Nonpregnant Cycling and Pregnant Animals
Estrous behavior in the nonpregnant intact sheep (n ¼ 11) was determined using a vasectomized ram, and surgery performed on day 3 to 4 post estrus. 7 On day 9 postestrus, the sheep was given 2 IM injections 4 hours apart of either lutalyse (follicular group-1 mg PGF 2a , Upjohn Pharmaceuticals, Kalamazoo, MI; n ¼ 7) or saline (luteal group-1 mL; n ¼ 4). Microsphere injections and reference samples were evaluated immediately prior to lutalyse or saline injection and at 6, 24, 44, 46, and 48 hours. There were no time-dependent changes in BBF in the saline controls; therefore, luteal phase BBF calculations were averaged within an animal and were based on all time points for the saline-injected sheep (day 5, 9-11) and pre-lutalyse injection (day 9). Follicular phase BBF from the lutalyse-injected animals was the average from 44 to 48 hours (day 11), which is during the peak estrous cycle periovulatory period when both the estrogen to progesterone ratio and the uterine blood flow are maximal. 2, 5, 7, 32 Pregnant sheep were studied at 120 to 130 days' gestation (term ¼ 147 days; n ¼ 6) and were given an injection of radioactive microspheres as described above after a control period of 60 to 120 minutes of established normal resting blood pressure, heart rate, and arterial blood gases.
Experimental Protocol for Oophorectomized Vehicle Versus ERT Animals
Oophorectomized (Ovx) sheep were monitored for 45 to 60 minutes to confirm resting blood pressure, heart rate, and arterial blood gases at which time the first microsphere injection was performed in 30 non-pregnant Ovx sheep. A subset of these sheep were given IV injections of either vehicle (10% ETOH in 3 mL saline; n ¼ 7) or E 2 b (5 mg/kg bolus over 1-2 minutes; n ¼ 9) followed immediately by 5-mL saline flush. Two hours after the E 2 b injection another microsphere injection was performed for blood flow measurements (ERT acute). Vehicle (95% ETOH) or E 2 b (6 mg/kg over 24 hours) infusions using Harvard syringes infusion pump (0.009 mL/min) were continued IV for 10 days in the same sheep, with additional microsphere injections and reference samples obtained at 3, 6, 8, and 10 days (ie, chronic, vehicle, or ERT, respectively).
Tissue Collection and Processing
After the last microsphere injection was performed, sheep were euthanized with an overdose of pentobarbital sodium (50-70 mg/kg). Tissues were weighed and placed into vials, and the level of radioactivity for each isotope per microsphere was determined as previously described. [1] [2] [3] 32 Bladder blood flow was calculated using following standard equation (withdrawal rate/ # of microspheres in reference blood) Â (# of microspheres in the tissue sample). Resistance was calculated as mean arterial blood pressure/regional blood flow. All bladder tissues had >400 microspheres/bladder.
Western Blotting for ERs Concentration
Bladder tissue from the dome of the bladder of 40 additional sheep was collected and snap frozen in liquid nitrogen at the time of sacrifice. All samples were stored at (À4 C) and subsequently were processed together for protein assay, Western blotting, probing, and analysis. The bladder tissues so obtained were matched to the following physiologic groups evaluated above for BBF (10 luteal, 8 follicular, 8 pregnant, 10 Ovx/Vehicle, 4 Ovx/Chronic Estrogen). Estrogen receptor a and ERb levels were evaluated with anti-human ERa and ERb antibodies (Neomarker, Fremont, CA and Santa Cruz, CA respectively). 33 Blots were designed with a pooled standard sample used to normalize differences in exposure or antibody binding. After enhanced chemolumenience probing, blots were scanned and analyzed with densitometry.
Statistical Analysis
Data were analyzed using a single tailed Student's t test. These data were analyzed as absolute flow (mL/min/g) and vascular resistance (mm Hg/mL/min/g), and values are reported as means + SE.
RESULTS
There were no time-dependent changes in bladder vascular resistance or BBF in the vehicle control animals; therefore, these data were averaged with the data from all Ovx sheep prior to any steroid treatments. The chronic ERT BBF responses were similar from days 3 through 10 of E 2 b infusion (P > .05); therefore, these data were averaged within each animal studied.
The ovarian cycle did not alter BBF, in that luteal phase sheep had a bladder vascular resistance (Table 1) and BBF (Figure 1 ) that were similar (P > .05) to follicular phase animals. When compared to luteal phase sheep, pregnancy was associated with a 1.5-fold increase (P < .01) in bladder vascular resistance, and BBF fell an average of 37% in pregnancy (P ¼ .021). Similarly, compared to luteal phase sheep, the Ovx vehicle-treated sheep had 2.2-fold higher bladder vascular resistance (P < .001) and 62% lower BBF (P < .001). When compared to Ovx/vehicle-treated sheep, acute ERT given to Ovx sheep dramatically lowered bladder vascular resistance by 81% (P < .01), increasing BBF 5.1-fold (P < .01). It is noteworthy that chronic ERT in Ovx sheep also maintained lower bladder vascular resistance (57%) and higher BBF (2.1-fold), that is, returning bladder vascular resistance and BBF similar to levels seen in luteal phase sheep (P > .05); however, this chronic estrogen response was reduced compared to acute ERT. We also observed that oopherectomy had no significant effects on bladder weight, whereas ERT increased bladder weight (Table 1) . This finding has been noted in the literature. 9, 21, 23, 28 Estrogen receptor a ( Figure 2 ) levels in bladder dome tissue predominated, while ERb levels were not detectable (data not shown). In intact sheep, the phase of the ovarian cycle did not alter ERa levels, although pregnancy was associated with a 73% increase in ERa levels (P < .05). Oophorectomized sheep had ERa bladder levels that were elevated (P < .05) by 19% compared to luteal phase bladder tissues. Chronic ERT in Ovx sheep did not significantly affect ERa levels, values remaining similar to the Ovx vehicle-treated sheep.
DISCUSSION
We observed that the dome of the bladder had primarily ERa with negligible levels of ERb. These findings are consistent with other studies that demonstrate ERb levels in the trigone of the bladder and urethra but not in the dome. 19 We selected this tissue site because overactive bladder symptoms in women are related to abnormalities in function of the dome of the bladder. [34] [35] [36] [37] [38] We observed that BBF and ERa levels were not significantly changed with fluctuations in endogenous estrogen levels during the ovarian cycle (Figure 1 ). This is also supported by studies measuring bladder blood velocity using Doppler ultrasound during the menstrual cycle in women, 13, 30 which suggested little if any variation in volumetric BBF. This is substantially different when compared to uterine tissue and other reproductive tissues, which exhibit substantially increased blood flow during high endogenous estrogen states such as the follicular phase of the ovarian cycle. 2, 4, 7, 8, 32 Indeed uterine tissue blood flows were elevated greatly during the periovulatory period in uteri collected from the same animals used for the current study (data no shown).
We observed that BBF levels fall and unexpectedly ERa levels rise with oopherectomy (Table 1; Figure 2 ). The fall of BBF and rise in ERa levels with oopherectomy suggest that decreased circulating estrogen levels and/or decreased BBF lead to a rise in ERs. When estrogen was replaced in a chronic manner, we observed a rise in BBF that approached levels seen in cycling follicular and luteal sheep. Our observations are consistent with data obtained from humans and other animal models on ERT. 9, 13, 21 The BBF responses to systemic estrogen in this study are also consistent with functional studies in humans and animal models, which show improved bladder function and in particular contractile activity. 1, 6, 12, 20, 23, 27, 31, [39] [40] [41] In the present study, we noted a significant rise in ERa levels with Ovx that was unexpectedly unchanged with chronic ERT. The reason for this is unclear and needs further investigation. This implies that unlike reproductive tissues, 2, 8, 33 factors other than tissue estrogen levels appear to modulate ER levels in the bladder.
We recognize and wish to point out a limitation of the current study compared to the human, in that all surgically menopausal sheep were not aged and were oopherectomized for only 7 to 15 days to achieve this state. Most symptomatic postmenopausal women have intact ovaries. It is possible that compounds produced by the ovary other than estrogen participate in modulating BBF. It is also possible that other diseases of aging may affect BBF in postmenopausal women 14, 36, 37, 42 or that progesterone may possibly be an important factor. 2, 6, 7 In this regard, preliminary data evaluating the effects of exogenous progesterone in Ovx sheep suggest that like the uterine circulation the acute (2 hours) estrogen BBF response is somewhat attenuated by progesterone. However, in Ovx sheep no overt BBF differences were noted in the chronic progesterone treatments compared to either chronic estrogen or vehicle alone (data not shown).
Several laboratories have studied the physiologic significance of blood flow changes as a result of estrogen. 1, 3, 43, 44 It is noteworthy that relative changes in blood flow in response to estrogen have been shown to be much greater in the reproductive vasculature than the systemic vasculature. The urogenital tissues and the tissues of the urogenital sinus have been show to be estrogen responsive whereas there are multiple tissues in which estrogen does not have any effect what so ever. 1 To this end, comparing blood flow during different hormonal states in any of the nonreproductive tissues is important. Other animal models have measured BBF; in Parekh et al 11 blood flow was measured in female rabbits where comparisons were made between intact and Ovx animals. Indeed their comparisons like these described herein also found significant reductions in blood flow with Ovx. They noted a 50% Ovx-induced reduction in blood flow to both the detrusor muscle and the urothelium, translating to a change in flow of 0.025 mL/min/g for detrusor muscle and a change of 0.17 mL/min/g for urothelium. In our study, full-thickness bladder samples were taken that included urothelium and detrusor muscle; we noted a 62% change in flow between intact (luteal) and Ovx ewes that translates to a change in flow of 0.113 mL/min/g. No literature comparisons are available for Ovx vehicle-treated versus Ovx ERT-treated (acute or chronic) or hormonally intact versus pregnant animals.
Although functional studies (eg, bladder contractility, capacity, etc) have not been performed as part of this investigation, there are functional studies in the literature in the premenopause, 12 post menopause, 11 and postmenopause with ERT groups. 9, 13 All these studies confirm decreased function with lower estrogen physiological states and a return of function with estrogen replacement. There are many bladder function surveys in women during these different hormonal states that again confirm the clinical significance of these findings. 45 During pregnancy, we unexpectedly observed a significant decrease in BBF and a rise in ERa levels. It is possible that this decrease in blood flow is due to shunting of blood from the bladder to the adjacent reproductive tissues. This would likely occur because the reproductive organs are much more sensitive to the vasodilatory effects of estrogen [1] [2] [3] [4] 31, 47 and have a relatively much greater fall in vascular resistance than the bladder. It is also possible that other regulatory factors may play a role in modulating the responsiveness of this organ during gestation. The ratio of estrogen to progesterone and the timing of exposure to these steroids is dramatically different during pregnancy than the ovarian cycle. 4, 5 Pregnancy is a chronic progesterone dominant state, but how these pregnancy levels or exogenous progesterone treatments versus luteal phase exposures affect BBF is unclear. It is of interest that functional studies in animals show that pregnancy improved bladder capacity and compliance. 48, 49 This is thought to be due to high circulating progesterone levels that lead to structural changes in the detrusor muscle. Functional studies in humans are less clear but do not show a decrease in bladder capacity. 50, 51 We also considered that an increase in urine production during pregnancy due to increased glomerular filtrations rates may be the cause of decreased blood flow as well as frequency and urge symptoms. Although this is briefly commented on for completeness sake, we do not feel very strongly that this is the exact mechanism for the fall in BBF in our model. In animals, this has been shown to be true if there is evidence of poor bladder compliance. 52 If the bladder has normal compliance, then studies have shown no decrease in blood flow during filling. 53 Because we expect that pregnancy improves bladder compliance, it is unlikely that increased urine production is the true mechanism for these symptoms. Many clinical studies 46, 54, 55 reveal that regardless of any changes in capacity and compliance, pregnant women uniformly complain of a marked increase in overactive bladder symptoms as early as the first trimester. Our findings of a fall in BBF during pregnancy may partly help explain this.
In summary, the bladder appears to respond to endogenous ovarian estrogen levels for tropic support of basal function rather than the cyclical changes seen in uterus and other reproductive organs. It is likely that during gestation the observed decreases in BBF are associated with the substantial alteration in pelvic organ hemodynamic redistribution and may contribute significantly to the clearly elevated overactive bladder symptoms reported throughout gestation.
